Go Deep
Abrdn Life Sciences Investors
Abrdn Life Sciences Investors Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,728 | 2.6 | 0.94 | 0.00 | 1,632.89 |
| Oct 2026 | 21,842 | 2.5 | 0.91 | 0.00 | 1,589.32 |
| Oct 2026 | 21,780 | 2.6 | 0.92 | 0.00 | 1,614.72 |
| Oct 2026 | 21,591 | 2.7 | 0.96 | 0.00 | 1,686.78 |
| Oct 2026 | 21,559 | 2.7 | 0.97 | 0.00 | 1,694.91 |
| Oct 2026 | 21,552 | 2.7 | 0.97 | 0.00 | 1,694.32 |
Abrdn Life Sciences Investors Quarterly Results
Quarterly data isn't available for this company right now.
Abrdn Life Sciences Investors Revenue & Profit
Annual financial data isn't available for this company right now.
Abrdn Life Sciences Investors Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Abrdn Life Sciences Investors owed $0.00 for every $1 it owned in Mar 2026, down from $0.04 in Sep 2022.
| Period | Mar 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.00× | 0.00× | 0.00× | 0.00× | 0.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Abrdn Life Sciences Investors Cash Flow
Cash flow data isn't available for this company right now.